Related references
Note: Only part of the references are listed.PALB2 mutations in German and Russian patients with bilateral breast cancer
Natalia Bogdanova et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Contribution of Inherited Mutations in the BRCA2-Interacting Protein PALB2 to Familial Breast Cancer
Silvia Casadei et al.
CANCER RESEARCH (2011)
Paired distribution of molecular subtypes in bilateral breast carcinomas
Hege G. Russnes et al.
CANCER GENETICS (2011)
Non-founder BRCA1 mutations in Russian breast cancer patients
Aglaya G. Iyevleva et al.
CANCER LETTERS (2010)
BRCA1 and BRCA2 mutations across race and ethnicity: distribution and clinical implications
Allison W. Kurian
CURRENT OPINION IN OBSTETRICS & GYNECOLOGY (2010)
LOH analysis should not be used as a tool to assess whether UVs of BRCA1/2 are pathogenic or not
E. Beristain et al.
FAMILIAL CANCER (2010)
RecQ helicases: multifunctional genome caretakers
Wai Kit Chu et al.
NATURE REVIEWS CANCER (2009)
Two sources of the Russian patrilineal heritage in their Eurasian context
Oleg Balanovsky et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2008)
Genetic Predisposition to Breast Cancer: Past, Present, and Future
Clare Turnbull et al.
Annual Review of Genomics and Human Genetics (2008)
Ovarian cancer patient with germline mutations in both BRCA1 and NBN genes
Nathalia V. Porhanova et al.
CANCER GENETICS AND CYTOGENETICS (2008)
CHEK2* 1100delC genotyping for clinical assessment of breast cancer risk:: Meta-analyses of 26,000 patient cases and 27,000 controls
Maren Weischer et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Polygenes, risk prediction, and targeted prevention of breast cancer
Paul D. P. Pharoah et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Carrier frequency of autosomal-recessive disorders in the Ashkenazi Jewish population: should the rationale for mutation choice for screening be reevaluated?
Fuad Fares et al.
PRENATAL DIAGNOSIS (2008)
Rising from the RecQ-age: the role of human RecQ helicases in genome maintenance
Vilhelm A. Bohr
TRENDS IN BIOCHEMICAL SCIENCES (2008)
Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations
James D. Fackenthal et al.
NATURE REVIEWS CANCER (2007)
Heterogenic loss of the wild-type BRCA allele in human breast tumorigenesis
Tari A. King et al.
ANNALS OF SURGICAL ONCOLOGY (2007)
Syndrome-causling mutations of the BLM gene in persons in the Bloom's syndrome registry
James German et al.
HUMAN MUTATION (2007)
Analysis of PALB2/FANCN-associated breast cancer families
Marc Tischkowitz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Founder mutations in BRCA1 and BRCA2 genes
R. Ferla et al.
ANNALS OF ONCOLOGY (2007)
Founder mutations in early-onset, familial and bilateral breast cancer patients from Russia
Anna P. Sokolenko et al.
FAMILIAL CANCER (2007)
The Bloom's syndrome helicase can promote the regression of a model replication fork
Christine Ralf et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
NBS1 657del5 mutation may contribute only to a limited fraction of breast cancer cases in Russia
KG Buslov et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Phenotypic expression of double heterozygosity for BRCA1 and BRCA2 germline mutations -: art. no. e20
B Leegte et al.
JOURNAL OF MEDICAL GENETICS (2005)
Coinheritance of BRCA1 and BRCA2 mutations with Fanconi anemia and bloom syndrome mutations in Ashkenazi Jewish population: Possible role in risk modification for cancer development
M Koren-Michowitz et al.
AMERICAN JOURNAL OF HEMATOLOGY (2005)
The Bloom's syndrome helicase suppresses crossing over during homologous recombination
L Wu et al.
NATURE (2003)
Mutation screening of Mre11 complex genes:: indication of RAD50 involvement in breast and ovarian cancer susceptibility -: art. no. e131
K Heikkinen et al.
JOURNAL OF MEDICAL GENETICS (2003)
CHEK2 variants in susceptibility to breast cancer and evidence of retention of the wild type allele in tumours
N Sodha et al.
BRITISH JOURNAL OF CANCER (2002)
Enhanced tumor formation in mice heterozygous for Blm mutation
KH Goss et al.
SCIENCE (2002)
BLM heterozygosity and the risk of colorectal cancer
SB Gruber et al.
SCIENCE (2002)
Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations
H Meijers-Heijboer et al.
NATURE GENETICS (2002)
Share Paper
